Jubilant HollisterStier

Private

#Sterile Fill-Finish #Lyophilization #Contract Manufacturing #Vaccine Production #Biologics Manufacturing

Jubilant HollisterStier is a Spokane, Washington-based contract manufacturing organization (CMO) specializing in sterile injectable fill-finish, lyophilization, and aseptic manufacturing for pharmaceutical and biopharmaceutical clients. The company is a subsidiary of Jubilant Pharma.

Company Info

Sector:Contract Manufacturing (Sterile Injectables)

Headquarters:Spokane, Washington, USA

Founded:1978

Website:www.jublhs.com/

Funding Round:Acquired by Novartis (2026)

Total Funding:Undisclosed (acquisition terms)

Funding & Investor Relations

IPO Outlook / Plans

N/A (private; acquired)

Upcoming Milestones & Key Dates

2026-08-12

Regulatory

FDA warning letter response re-inspection

2026-09-22

Conference

Contract Pharma Conference

Clinical Development Pipeline

Sterile injectable manufacturing capacity expansion

Target: Vial and syringe fill-finish

Multi-client contract manufacturing

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Lyophilization suite (Suite C)

Target: Lyophilized vial

Large-molecule biologics lyophilization

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Foreign Trade Zone (FTZ) expansion

Target: FTZ-licensed storage and distribution

International pharma logistics

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Jubilant draws FDA rebuke for delayed mold investigation and quality unit lapses ↗

Jubilant HollisterStier received an FDA warning letter citing delayed mold investigation and quality unit lapses at its Spokane, Washington contract-manufacturing facility, prompting an immediate and comprehensive assessment of the CMO's global operations.

Leadership Team

Chris Preti

Chief Executive Officer

Amit Arora

Chief Operating Officer

Mark Szczepanski

Vice President, Quality

Careers & Job Openings

See all open roles

Various

Apply Now →